Connect with us
The clever new way to send money abroad

India

Thailand worried about India-EU free trade agreement

As informal talks have started between India and Europe on the free trade agreement (FTA) in New Delhi since Monday, apprehensions over provisions that could impact early access to generic medicines are being voiced in Thailand.

Published

on

drug pile

Formal talks on the FTA would start in Brussels in April and India and EU have both expressed an explicit desire to sign the FTA by 2010. As informal talks have started between India and Europe on the free trade agreement (FTA) in New Delhi since Monday, apprehensions over provisions that could impact early access to generic medicines are being voiced in Thailand.

India is a major supplier of key HIV/AIDS drugs such as efavirenz, and heat stable lopinavir/ritonavir to the National Health Security scheme of the Thai government, which ensures free access to treatment for all Thais.

Concerns expressed by Thais range from patent term extensions, data exclusivity, criminalisation of patents enforcement (see bullet points), said to be a part of the FTA, is heavily shrouded in secrecy, with the texts and content of the deal guarded from any parliamentary debate or discussion.

Kannikar Kijtiwatchakul, coordinator, health consumer protection programme, Chulalongkom University in Thailand said that India is the pharmacy of the developing world, particularly Thailand.

According to Amit Sengupta, general secretary, All India Peoples Science Network, “India agreed to grant patents to medicines by signing Trips. Now with this FTA, EU is trying to force India to adopt higher standards of intellectual property. India has a moral and legal right to say no.”

Formal talks on the FTA would start in Brussels in April and India and EU have both expressed an explicit desire to sign the FTA by 2010.

India is a major supplier of key HIV/AIDS drugs such as efavirenz, and heat stable lopinavir/ritonavir to the National Health Security scheme of the Thai government, which ensures free access to treatment for all Thais.

Concerns expressed by Thais range from patent term extensions, data exclusivity, criminalisation of patents enforcement (see bullet points), said to be a part of the FTA, is heavily shrouded in secrecy, with the texts and content of the deal guarded from any parliamentary debate or discussion.

Kannikar Kijtiwatchakul, coordinator, health consumer protection programme, Chulalongkom University in Thailand said that India is the pharmacy of the developing world, particularly Thailand.

Formal talks on the FTA would start in Brussels in April and India and EU have both expressed an explicit desire to sign the FTA by 2010.

India is a major supplier of key HIV/AIDS drugs such as efavirenz, and heat stable lopinavir/ritonavir to the National Health Security scheme of the Thai government, which ensures free access to treatment for all Thais.

Concerns expressed by Thais range from patent term extensions, data exclusivity, criminalisation of patents enforcement (see bullet points), said to be a part of the FTA, is heavily shrouded in secrecy, with the texts and content of the deal guarded from any parliamentary debate or discussion.

Kannikar Kijtiwatchakul, coordinator, health consumer protection programme, Chulalongkom University in Thailand said that India is the pharmacy of the developing world, particularly Thailand.

From : DNA

Click to comment

Leave a Reply

Asean

Opportunities for Indian Manufacturers in ASEAN

Indian exports largely mirror those of ASEAN states, such as rice, electrical equipment, and clothing and accessories. However, there are still sectors where Indian exporters can potentially exploit market needs – wheat exports, the digital economy, and healthcare.

Published

on

Opportunities for Indian Manufacturers in ASEAN

The economic partnership between India and the Association of Southeast Asian Nations (ASEAN) has continued to strengthen since the economic relationship began in 1992 and with the ASEAN-India Free Trade Agreement (AIFTA) coming into effect in 2009.

(more…)
Continue Reading

Asean

India, ASEAN Agree to Review FTA Scope, Address Uneven Market Access

Chief among India’s concerns is that Indian exporters have been denied a level playing field in the Southeast Asian market. Moreover, New Delhi believes that China has taken undue advantage of the ASEAN-India FTA (AIFTA) due to weak rules of origin.

Published

on

India, ASEAN Agree to Review FTA Scope, Address Uneven Market Access

The 8th East Asia Summit (Economic Ministers’ Meeting) was held virtually on Friday, followed by the 17th ASEAN-India Economic Ministers Consultations on August 29.

(more…)
Continue Reading

Most Read

Recent